Company Overview and News
It has been about a month since the last earnings report for Kohl's (KSS - Free Report) . Shares have added about 0.6% in that time frame, underperforming the S&P 500.
Target (NYSE:TGT) announced Thursday that it is set to hire 20% more seasonal workers during the upcoming holiday shopping period, with a sizeable amount dedicated to online order fulfillment. TGT, along with Walmart (NYSE:WMT) and other retail powers are coming off a strong second quarter. Now, Target stock looks like it might be worth buying ahead of what could be a big holiday shopping season.
TGT AMZN COST KSS M WMT
It’s been a great start to the week for Foot Locker (NYSE:FL). Keep in mind that the shares have been in a downtrend during the past three months. But as of Monday, Foot Locker stock jumped by 5%.
WFC WFCNP WMT TGT AMZN NKE KSS FL
In the latest trading session, Kohl's (KSS - Free Report) closed at $81.10, marking a -1.17% move from the previous day. This move lagged the S&P 500's daily loss of 0.28%. At the same time, the Dow added 0.09%, and the tech-heavy Nasdaq lost 1.19%.
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
Shares of athletic apparel brand Under Armour (NYSE:UAA) dropped on Wednesday after Dick’s Sporting Goods (NYSE:DKS) pointed to weakness with the Under Armour brand in its second-quarter earnings report. UAA stock dropped to $20 on the news.
UA NKE UAA DKS KSS
2018-08-31 seekingalpha - 1
After beating EPS and top-line estimates and $100 million buyback complete, management boosts revenue and EPS guidance for the year.
SHOP BPY M WMT JWN AMZN CBG DCF KSS MSFT CAG MANH CBRE DF
Ninety percent of the companies in our Retail/Restaurant Index have reported Q2 2018 EPS. Of the 190 companies in the index that have reported earnings to date, 74% have reported earnings above analyst expectations, 7% reported earnings in line with analyst expectations and 19% reported earnings below analyst expectations. The Q2 2018 blended earnings growth estimate is 29.7%.
TGT JWN TIF AMZN KSS BBY WMT
It’s confession time: I’ve never really been convinced that Under Armour (NYSE:UA, NYSE:UAA) is a solid investment. While its products resonate with its core customers, that engagement hasn’t translated to market success. Compared against two years ago, Under Armour stock has declined to roughly half its value.
UA NKE UAA DKS KSS
Kohl's Corporation’s (KSS - Free Report) shares have surged considerably and more than doubled in a year’s time, comfortably beating the industry’s growth of almost 75%. The company has been gaining from its sturdy comparable store sales (comps) trend, which is backed by its constant efforts to drive sales. Kohl’s has been making robust efforts to draw shoppers and improve sales, which have helped the company deliver positive comps for four straight quarters now.
UA NKE UAA KSS NVMI SMG
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to KSS / Kohl's Corp. on message board site Silicon Investor.
as of ET